SP1 and keratoconus: Sp1 is believed to play a role in keratoconus disease progression by supporting the increased expression of degradative enzymes such as cathepsin-B and suppression of proteinase inhibitors such as α1-proteinase inhibitor (α1-PI) [156, 157].